Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

1.

Superior Long-Term Survival for Simultaneous Pancreas-Kidney Transplantation as Renal Replacement Therapy: 30-Year Follow-up of a Nationwide Cohort.

Esmeijer K, Hoogeveen EK, van den Boog PJM, Konijn C, Mallat MJK, Baranski AG, Dekkers OM, de Fijter JW; Dutch Transplant Centers; Dutch Kidney Transplant Centres.

Diabetes Care. 2019 Dec 4. pii: dc191580. doi: 10.2337/dc19-1580. [Epub ahead of print]

PMID:
31801788
2.

Plasma Vitamin C and Cancer Mortality in Kidney Transplant Recipients.

Gacitúa TA, Sotomayor CG, Groothof D, Eisenga MF, Pol RA, Borst MH, Gans ROB, Berger SP, Rodrigo R, Navis GJ, Bakker SJL.

J Clin Med. 2019 Nov 23;8(12). pii: E2064. doi: 10.3390/jcm8122064.

3.

Plasma versus Erythrocyte Vitamin E in Renal Transplant Recipients, and Duality of Tocopherol Species.

Sotomayor CG, Rodrigo R, Gomes-Neto AW, Gormaz JG, Pol RA, Minović I, Eggersdorfer ML, Vos M, Riphagen IJ, de Borst MH, Nolte IM, Berger SP, Navis GJ, Bakker SJL.

Nutrients. 2019 Nov 19;11(11). pii: E2821. doi: 10.3390/nu11112821.

4.

Urinary Properdin and sC5b-9 Are Independently Associated With Increased Risk for Graft Failure in Renal Transplant Recipients.

Lammerts RGM, Eisenga MF, Alyami M, Daha MR, Seelen MA, Pol RA, van den Born J, Sanders JS, Bakker SJL, Berger SP.

Front Immunol. 2019 Oct 24;10:2511. doi: 10.3389/fimmu.2019.02511. eCollection 2019.

5.

Urinary Epidermal Growth Factor/Creatinine Ratio and Graft Failure in Renal Transplant Recipients: A Prospective Cohort Study.

Yepes-Calderón M, Sotomayor CG, Kretzler M, Gans ROB, Berger SP, Navis GJ, Ju W, Bakker SJL.

J Clin Med. 2019 Oct 13;8(10). pii: E1673. doi: 10.3390/jcm8101673.

6.

Intraoperative Fluid Restriction is Associated with Functional Delayed Graft Function in Living Donor Kidney Transplantation: A Retrospective Cohort Analysis.

Nieuwenhuijs-Moeke GJ, Huijink TM, Pol RA, El Moumni M, Burgerhof JG, Struys MM, Berger SP.

J Clin Med. 2019 Oct 2;8(10). pii: E1587. doi: 10.3390/jcm8101587.

7.

Urinary Taurine Excretion and Risk of Late Graft Failure in Renal Transplant Recipients.

Post A, Said MY, Gomes-Neto AW, van der Krogt J, de Blaauw P, Berger SP, Geleijnse JM, Borgonjen K, van den Berg E, van Goor H, Rimbach G, Kema IP, Tsikas D, Heiner-Fokkema MR, Bakker SJL.

Nutrients. 2019 Sep 13;11(9). pii: E2212. doi: 10.3390/nu11092212.

8.

Kidney temperature during living donor kidney transplantation is associated with short-term measured glomerular filtration rate - a prospective study.

Benjamens S, van den Berg TAJ, Kuipers TGJ, Moers C, Berger SP, Leuvenink HGD, Pol RA.

Transpl Int. 2019 Sep 20. doi: 10.1111/tri.13528. [Epub ahead of print]

PMID:
31538677
9.

Circulating Advanced Glycation Endproducts and Long-Term Risk of Cardiovascular Mortality in Kidney Transplant Recipients.

Sotomayor CG, Gomes-Neto AW, van Londen M, Gans ROB, Nolte IM, Berger SP, Navis GJ, Rodrigo R, Leuvenink HGD, Schalkwijk CG, Bakker SJL.

Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1512-1520. doi: 10.2215/CJN.00540119. Epub 2019 Sep 17.

PMID:
31530552
10.

Administration of Intravenous Iron Formulations Induces Complement Activation in-vivo.

Faria B, Gaya da Costa M, Poppelaars F, Franssen CFM, Pestana M, Berger SP, Daha MR, Gaillard CAJM, Seelen MA.

Front Immunol. 2019 Aug 21;10:1885. doi: 10.3389/fimmu.2019.01885. eCollection 2019.

11.

Chronic Use of Proton-Pump Inhibitors and Iron Status in Renal Transplant Recipients.

Douwes RM, Gomes-Neto AW, Eisenga MF, Vinke JSJ, de Borst MH, van den Berg E, Berger SP, Touw DJ, Hak E, Blokzijl H, Navis G, Bakker SJL.

J Clin Med. 2019 Sep 3;8(9). pii: E1382. doi: 10.3390/jcm8091382.

12.

Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients.

Pascual J, Berger SP, Chadban SJ, Citterio F, Kamar N, Hesselink DA, Legendre C, Eisenberger U, Oppenheimer F, Russ GR, Sommerer C, Rigotti P, Srinivas TR, Watarai Y, Henry ML, Vincenti F, Tedesco-Silva H.

Transplant Rev (Orlando). 2019 Oct;33(4):191-199. doi: 10.1016/j.trre.2019.07.001. Epub 2019 Jul 23. Review.

PMID:
31377099
13.

Performance of a web-based application measuring spot quality in dried blood spot sampling.

Veenhof H, Koster RA, Brinkman R, Senturk E, Bakker SJL, Berger SP, Akkerman OW, Touw DJ, Alffenaar JC.

Clin Chem Lab Med. 2019 Nov 26;57(12):1846-1853. doi: 10.1515/cclm-2019-0437.

PMID:
31373896
14.

Limited clinical value of two consecutive post-transplant renal scintigraphy procedures.

Benjamens S, Pol RA, Berger SP, Glaudemans AWJM, Dibbets-Schneider P, Slart RHJA, de Geus-Oei LF.

Eur Radiol. 2020 Jan;30(1):452-460. doi: 10.1007/s00330-019-06334-1. Epub 2019 Jul 23.

PMID:
31338652
15.

Equivalent Long-term Transplantation Outcomes for Kidneys Donated After Brain Death and Cardiac Death: Conclusions From a Nationwide Evaluation.

Schaapherder A, Wijermars LGM, de Vries DK, de Vries APJ, Bemelman FJ, van de Wetering J, van Zuilen AD, Christiaans MHL, Hilbrands LH, Baas MC, Nurmohamed AS, Berger SP, Alwayn IP, Bastiaannet E, Lindeman JHN.

EClinicalMedicine. 2018 Oct 9;4-5:25-31. doi: 10.1016/j.eclinm.2018.09.007. eCollection 2018 Oct-Nov.

16.

Impact of Cold Ischemia Time on Outcomes of Deceased Donor Kidney Transplantation: An Analysis of a National Registry.

Peters-Sengers H, Houtzager JHE, Idu MM, Heemskerk MBA, van Heurn ELW, Homan van der Heide JJ, Kers J, Berger SP, van Gulik TM, Bemelman FJ.

Transplant Direct. 2019 Apr 25;5(5):e448. doi: 10.1097/TXD.0000000000000888. eCollection 2019 May.

17.

Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study.

Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Gutierrez MPH, Marti AM, Bernhardt P, Pascual J; TRANSFORM investigators.

Am J Transplant. 2019 Nov;19(11):3018-3034. doi: 10.1111/ajt.15480. Epub 2019 Jul 1.

PMID:
31152476
18.

Antiviral-resistant cytomegalovirus infections in solid organ transplantation in the Netherlands.

Van Leer Buter CC, de Voogd DWK, Blokzijl H, de Joode AAE, Berger SP, Verschuuren EAM, Niesters HGM.

J Antimicrob Chemother. 2019 Aug 1;74(8):2370-2376. doi: 10.1093/jac/dkz196.

PMID:
31093660
19.

Plasma Malondialdehyde and Risk of New-Onset Diabetes after Transplantation in Renal Transplant Recipients: A Prospective Cohort Study.

Yepes-Calderón M, Sotomayor CG, Gomes-Neto AW, Gans ROB, Berger SP, Rimbach G, Esatbeyoglu T, Rodrigo R, Geleijnse JM, Navis GJ, Bakker SJL.

J Clin Med. 2019 Apr 4;8(4). pii: E453. doi: 10.3390/jcm8040453.

20.

Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients.

Veenhof H, Koster RA, Alffenaar JC, van den Berg AP, de Groot MR, Verschuuren EAM, Berger SP, Bakker SJL, Touw DJ.

Clin Chem Lab Med. 2019 Nov 26;57(12):1854-1862. doi: 10.1515/cclm-2019-0053.

PMID:
30939110

Supplemental Content

Loading ...
Support Center